From the magazine

NEW PRODUCT: NanoSalv Catalytic gel for wound care

Get the info you need on this new product, part of our drug news roundup for June.
NEW DRUG: Andembry for hereditary angioedema prevention

Get the info you need on this new product, part of our drug news roundup for June.
Social studies: how pharmacists are using social media to grow their reputation—and their business

It can be hard to stand out from the crowd as a pharmacist.
Dependence risk with benzodiazepines, z-drugs and gabapentinoids

In the U.K., safety warnings for benzodiazepines, z-drugs and gabapentinoids have been strengthened.
The hunger for a better business

We’ve always believed that there is a strong correlation between excellence in pharmacy practice and success in pharmacy business. (It’s in our name, after all!)
Is it okay to use type 2 diabetes medications in people with type 1 diabetes?

Recently, I was approached by a colleague who had seen a patient with type 1 diabetes using a glucagon-like peptide-1 receptor agonist in combination with basal bolus insulin to manage their glucose levels.
The cost of defensive med

Why psychological safety matters in physician regulation.
Problem solved: How do I make my EMR work for me?

We asked, your colleagues answered! See what they had to say about making sure your EMR is making your life easier.

Postpartum depression: current care and an emerging option